378 related articles for article (PubMed ID: 31243493)
21. Role of Pregabalin in Management of Pruritus: A Literature Review.
Foroutan N; Nikvarz N
J Pharm Pharm Sci; 2016; 19(4):465-474. PubMed ID: 28057164
[TBL] [Abstract][Full Text] [Related]
22. Use of Butorphanol as Treatment for Cholestatic Itch.
Golpanian RS; Yosipovitch G; Levy C
Dig Dis Sci; 2021 May; 66(5):1693-1699. PubMed ID: 32556969
[TBL] [Abstract][Full Text] [Related]
23. Fibrates for the treatment of cholestatic itch (FITCH): study protocol for a randomized controlled trial.
Bolier R; de Vries ES; Parés A; Helder J; Kemper EM; Zwinderman K; Elferink RPO; Beuers U;
Trials; 2017 May; 18(1):230. PubMed ID: 28535810
[TBL] [Abstract][Full Text] [Related]
24. Gabapentin in the treatment of uremic itch: an index case and a pilot evaluation.
Manenti L; Vaglio A; Costantino E; Danisi D; Oliva B; Pini S; Prati E; Testori A
J Nephrol; 2005; 18(1):86-91. PubMed ID: 15772928
[TBL] [Abstract][Full Text] [Related]
25. Antipruritic treatment with systemic μ-opioid receptor antagonists: a review.
Phan NQ; Bernhard JD; Luger TA; Ständer S
J Am Acad Dermatol; 2010 Oct; 63(4):680-8. PubMed ID: 20462660
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological Characterization of a Novel Mouse Model of Cholestatic Pruritus.
Andoh T; Suzuki K; Konno M; Tsuneyama K; Kuraishi Y
Biol Pharm Bull; 2020; 43(7):1111-1117. PubMed ID: 32612073
[TBL] [Abstract][Full Text] [Related]
27. Small molecule drugs for the treatment of pruritus in patients with atopic dermatitis.
Soeberdt M; Kilic A; Abels C
Eur J Pharmacol; 2020 Aug; 881():173242. PubMed ID: 32504692
[TBL] [Abstract][Full Text] [Related]
28. Long-term efficacy and safety of nalfurafine hydrochloride on pruritus in chronic liver disease patients: Patient-reported outcome based analyses.
Kamimura K; Yokoo T; Kamimura H; Sakamaki A; Abe S; Tsuchiya A; Takamura M; Kawai H; Yamagiwa S; Terai S
PLoS One; 2017; 12(6):e0178991. PubMed ID: 28604788
[TBL] [Abstract][Full Text] [Related]
29. Antidepressants as antipruritic agents: A review.
Kaur R; Sinha VR
Eur Neuropsychopharmacol; 2018 Mar; 28(3):341-352. PubMed ID: 29456150
[TBL] [Abstract][Full Text] [Related]
30. Prurigo Nodularis and Its Management.
Zeidler C; Yosipovitch G; Ständer S
Dermatol Clin; 2018 Jul; 36(3):189-197. PubMed ID: 29929592
[TBL] [Abstract][Full Text] [Related]
31. Role of gabapentin in the treatment of uremic pruritus.
Vila T; Gommer J; Scates AC
Ann Pharmacother; 2008 Jul; 42(7):1080-4. PubMed ID: 18492782
[TBL] [Abstract][Full Text] [Related]
32. Uremic pruritus in chronic hemodialysis patients.
Narita I; Iguchi S; Omori K; Gejyo F
J Nephrol; 2008; 21(2):161-5. PubMed ID: 18446709
[TBL] [Abstract][Full Text] [Related]
33. Novel drugs for the treatment of chronic pruritus.
Pereira MP; Ständer S
Expert Opin Investig Drugs; 2018 Dec; 27(12):981-988. PubMed ID: 30426802
[TBL] [Abstract][Full Text] [Related]
34. Immunomodulating Agents as Antipruritics.
Erickson S; Nahmias Z; Rosman IS; Kim BS
Dermatol Clin; 2018 Jul; 36(3):325-334. PubMed ID: 29929604
[TBL] [Abstract][Full Text] [Related]
35. A review of pruritus.
Denman ST
J Am Acad Dermatol; 1986 Mar; 14(3):375-92. PubMed ID: 3514695
[TBL] [Abstract][Full Text] [Related]
36. Difelikefalin (Korsuva) for chronic kidney disease-associated pruritus.
Med Lett Drugs Ther; 2022 Feb; 64(1643):18-19. PubMed ID: 35134047
[No Abstract] [Full Text] [Related]
37. Pregabalin treatment of three cases with brachioradial pruritus.
Atış G; Bilir Kaya B
Dermatol Ther; 2017 Mar; 30(2):. PubMed ID: 28168835
[TBL] [Abstract][Full Text] [Related]
38. Advances in therapeutic strategies for the treatment of pruritus.
Stull C; Lavery MJ; Yosipovitch G
Expert Opin Pharmacother; 2016; 17(5):671-87. PubMed ID: 26630350
[TBL] [Abstract][Full Text] [Related]
39. Antipruritic Effects of Kappa Opioid Receptor Agonists: Evidence from Rodents to Humans.
Inan S; Cowan A
Handb Exp Pharmacol; 2022; 271():275-292. PubMed ID: 33296031
[TBL] [Abstract][Full Text] [Related]
40. Clinically meaningful change in itch intensity scores: An evaluation in patients with chronic kidney disease-associated pruritus.
Vernon M; Ständer S; Munera C; Spencer RH; Menzaghi F
J Am Acad Dermatol; 2021 Apr; 84(4):1132-1134. PubMed ID: 32603719
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
